Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Exciting updates from our content and strategy team

April 23, 2025 |  

Cuttsy+Cuttsy celebrates new beginnings with the appointment of Oli Bailey as Strategy Director and recognises team excellence through several well-deserved promotions.

Content team

As we usher in the new financial year, we are pleased to welcome a new Strategy Director to Cuttsy+Cuttsy and celebrate the accomplishments of our talented team members through some well-deserved promotions.

At the beginning of the month, we welcomed Oli Bailey as our new Strategy Director. As Strategy Director, Oli brings a critical perspective to Cuttsy+Cuttsy, guiding our approach to develop impactful solutions that resonate with our clients and the patients and communities we support. Oli carries a wealth of experience in healthcare communications, that will be invaluable to our team as we continue to grow and evolve.

Speaking about joining the team, Oli shared, “I’m incredibly excited to join such a talented and passionate group of individuals. It’s clear that this agency is driven by a commitment to creating work that truly matters, and I can’t wait to get started on helping to shape the strategy that will keep us at the forefront of healthcare communications.”

But that’s not all! We also had some amazing growth within our Content and Strategy team this month. We’re proud to announce several well-deserved promotions that highlight the hard work, passion, and dedication of our talented colleagues:

Scott Palmer: promoted to Principal Patient Writer

Beth Bhuva: promoted to Principal Medical Writer

Katie Breen: promoted to Senior Patient Writer

These promotions are a testament to their commitment to creating content that truly makes a difference in people’s lives. Their efforts have consistently raised the bar, and we couldn’t be prouder of their achievements. Congratulations to all three of them on these exciting milestones!

Here’s to a month of growth, new beginnings, and well-earned recognition. We’re excited for what the future holds for the team and look forward to seeing their continued impact.

This content was provided by Cuttsy + Cuttsy

Company Details

Cuttsy and Cuttsy Logo

Cuttsy + Cuttsy

Email
Website

 Latest Content from  Cuttsy + Cuttsy 

Cuttsy+Cuttsy welcomes three new experts to the team

Cuttsy+Cuttsy is happy to be welcoming three new people to the team this month.

The gap between hype and reality, what patients really say about weight loss drugs

Explore real patient conversations about weight loss drugs, uncovering challenges, support strategies, and the critical need for clear, reliable healthcare communication.

Why patient-centricity depends on site-centricity in clinical trials

Explore why patient-centricity in clinical trials relies on site-centricity, emphasising the need to design trials that empower site teams to better support patients.

From cloudy to clear: visualising complex data privacy information

Discover how clear communication principles can transform complex clinical research topics, as we conclude our Health Literacy series with a practical example on participant data transparency.

UK clinical trial regs are changing — here’s what’s happening

Discover the transformative updates to UK clinical trial regulations, effective from April 2026, and learn how they aim to enhance transparency, participant safety, and trial efficiency.

The invisible influence on trial retention: why caregivers must be part of the plan

Caregivers are vital to clinical trial retention, yet often overlooked—this article highlights their challenges, impact, and how to better support them.

Where it all began: why we wrote ‘The Site Factor’

Discover the story behind ‘The Site Factor’ and how understanding site teams’ experiences can transform clinical trials for participants and researchers alike.

From text to context: Helping patients see side effects clearly

Discover how thoughtful design, clear language, and structured visuals can transform overwhelming side effect information into accessible, actionable insights for patients in our latest Health Literacy series.

Why patient engagement must come first in rare disease trials

Explore why patient engagement is the cornerstone of successful rare disease trials, emphasising the importance of designing studies around the realities of patients' lives to build trust and improve outcomes.

New Cuttsy+Cuttsy research shows why site support matters more than ever

Cuttsy+Cuttsy's upcoming report, 'The site factor: Where protocol meets practice in clinical trials', delves into the critical role of site staff in clinical research, offering insights into their daily challenges,...